275 related articles for article (PubMed ID: 26068566)
21. Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
Anwar M; Law R; Schier J
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(29):748-9. PubMed ID: 27466822
[TBL] [Abstract][Full Text] [Related]
22. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
Loeffler G; Hurst D; Penn A; Yung K
Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
[TBL] [Abstract][Full Text] [Related]
23. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
24. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
25. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
Lisi DM
JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
[TBL] [Abstract][Full Text] [Related]
27. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
[No Abstract] [Full Text] [Related]
28. Relating calls to US poison centers for potential exposures to medications to Centers for Disease Control and Prevention reporting of influenza-like illness.
Beauchamp GA; McKeown NJ; Rodriguez S; Spyker DA
Clin Toxicol (Phila); 2016 Mar; 54(3):235-40. PubMed ID: 26818907
[TBL] [Abstract][Full Text] [Related]
29. A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers.
Warrick BJ; Hill M; Hekman K; Christensen R; Goetz R; Casavant MJ; Wahl M; Mowry JB; Spiller H; Anderson D; Aleguas A; Gummin D; Thomas R; Nezlek C; Smolinske S
Ann Emerg Med; 2013 Sep; 62(3):244-51. PubMed ID: 23540815
[TBL] [Abstract][Full Text] [Related]
30. "Bath salts" and "plant food" products: the experience of one regional US poison center.
Murphy CM; Dulaney AR; Beuhler MC; Kacinko S
J Med Toxicol; 2013 Mar; 9(1):42-8. PubMed ID: 22733603
[TBL] [Abstract][Full Text] [Related]
31. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
32. Synthetic cannabinoid and marijuana exposures reported to poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
[TBL] [Abstract][Full Text] [Related]
33. Spice/K2 drugs--more than innocent substitutes for marijuana.
Zawilska JB; Wojcieszak J
Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
[TBL] [Abstract][Full Text] [Related]
34. Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.
Cordeiro SK; Daro RC; Seung H; Klein-Schwartz W; Kim HK
Addiction; 2018 Oct; 113(10):1850-1861. PubMed ID: 29806885
[TBL] [Abstract][Full Text] [Related]
35. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017.
Carpenter JE; Murray BP; Dunkley C; Kazzi ZN; Gittinger MH
Clin Toxicol (Phila); 2019 Apr; 57(4):282-286. PubMed ID: 30430874
[TBL] [Abstract][Full Text] [Related]
36. Synthetic Cannabinoids.
Mills B; Yepes A; Nugent K
Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
[TBL] [Abstract][Full Text] [Related]
37. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
[TBL] [Abstract][Full Text] [Related]
38. Synthetic cannabinoids: Variety is definitely not the spice of life.
Langford AM; Bolton JR
J Forensic Leg Med; 2018 Oct; 59():36-38. PubMed ID: 30130700
[TBL] [Abstract][Full Text] [Related]
39. Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1016-7. PubMed ID: 24336136
[TBL] [Abstract][Full Text] [Related]
40. Characterization of edible marijuana product exposures reported to United States poison centers.
Cao D; Srisuma S; Bronstein AC; Hoyte CO
Clin Toxicol (Phila); 2016 Nov; 54(9):840-846. PubMed ID: 27418198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
